Dr. Danilkovitch has been with the company since 2003 and has participated in the development of innovative scientific ideas in regenerative medicine. Prior to Osiris, she conducted research at the National Cancer Institute of National Institutes of Health.
Osiris Therapeutics focuses on researching, developing and marketing regenerative medicine products.
More articles on devices:
8 key trends in the North American orthobiologics market
DJO global names Jeanine Kestler EVP, chief HR officer
SpineGuard Q1 revenue up 27%: 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
